Westby Keith 4
4 · IVERIC bio, Inc. · Filed May 3, 2023
Insider Transaction Report
Form 4
IVERIC bio, Inc.ISEE
Westby Keith
SVP & COO
Transactions
- Exercise/Conversion
Common Stock
2023-05-01$4.52/sh+8,786$39,713→ 48,438 total - Sale
Common Stock
2023-05-01$37.12/sh−8,786$326,136→ 39,652 total - Exercise/Conversion
Common Stock
2023-05-01$5.22/sh+11,214$58,537→ 50,866 total - Sale
Common Stock
2023-05-01$37.12/sh−11,214$416,264→ 39,652 total - Exercise/Conversion
Common Stock
2023-05-02$2.94/sh+20,000$58,800→ 59,652 total - Sale
Common Stock
2023-05-02$37.81/sh−20,000$756,200→ 39,652 total - Exercise/Conversion
Stock Option (right to buy)
2023-05-01$4.52/sh−8,786$39,713→ 0 totalExercise: $4.52Exp: 2027-01-29→ Common Stock (8,786 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-05-01$5.22/sh−11,214$58,537→ 63,786 totalExercise: $5.22Exp: 2029-12-08→ Common Stock (11,214 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-05-02$2.94/sh−20,000$58,800→ 120,000 totalExercise: $2.94Exp: 2027-12-18→ Common Stock (20,000 underlying)
Footnotes (6)
- [F1]The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2022.
- [F2]The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $36.79 to $37.50 per share on May 1, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- [F3]The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $37.63 to $38.04 per share on May 2, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- [F4]This stock option award was granted on January 30, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
- [F5]This stock option award was granted on December 9, 2019 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
- [F6]This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.